Newsroom

Sorted by: Latest

-

Wolters Kluwer brings secure board meeting management to Germany with Legisway Meetings

HÜRTH, Germany--(BUSINESS WIRE)--Wolters Kluwer Legal & Regulatory today announced the launch of Legisway Meetings in Germany. Legisway Meetings supports company governance boards, supervisory boards, and corporate secretariats in preparing, conducting, and documenting meetings in a secure and structured way, tailored to the increasing governance, accountability, and compliance requirements faced by German organisations. Legisway Meetings is part of the Legisway Suite, Wolters Kluwer’s lega...
-

LMR Naturals to Showcase Leadership in Natural Ingredients at SIMPPAR, the International Exhibition of Raw Materials for Perfumery

GRASSE, France--(BUSINESS WIRE)--LMR Naturals by IFF — a global leader in natural ingredients for perfumery, cosmetics and flavors — will debut its latest innovations at the International Exhibition of Raw Materials for Perfumery (SIMPPAR), May 26–27 in Grasse. During the industry event, IFF will unveil new additions to its LMR Hearts collection, highlighting its naturals expertise and pioneering science. “Responsible innovation has always been central to LMR,” said Bertrand de Préville, genera...
-

Wolters Kluwer bringt sichere digitale Sitzungsverwaltung für Vorstände und Aufsichtsräte nach Deutschland mit Legisway Meetings

HÜRTH, Deutschland--(BUSINESS WIRE)--Wolters Kluwer Legal & Regulatory gibt heute die Einführung von Legisway Meetings in Deutschland bekannt. Legisway Meetings unterstützt Vorstände, Aufsichtsräte und Sekretariate bei der sicheren und strukturierten Vorbereitung, Durchführung und Dokumentation von Sitzungen. Die Lösung ist zugeschnitten auf die wachsenden Anforderungen an Governance, Rechenschaft und Compliance in deutschen Unternehmen. Legisway Meetings ist Teil der Legisway Suite, der Le...
-

Criteo Selects Navan to Modernize Global Travel Management

PALO ALTO, Calif.--(BUSINESS WIRE)--Navan (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced that it has been selected by Criteo, the global commerce intelligence platform, to modernize its global travel program. Criteo set out to provide its global workforce with an easy-to-use travel booking experience that brought visibility and control to its travel spending. Prioritizing operational excellence and employee experience, Criteo selected Navan because o...
-

Accenture Partners with the WTA to Help Build the Future of Women’s Tennis

ROME--(BUSINESS WIRE)--Accenture and the Women’s Tennis Association have announced a new, multi-year partnership....
-

ams OSRAM Delivers Strong Q1 Results, Enters AI Market Through a Development Agreement With a Leading AI Photonics Customer and Sees Path to Positive Free Cash Flow in 2027

PREMSTÄTTEN, Austria and MUNICH--(BUSINESS WIRE)--ams OSRAM (SWX:AMS): Key Performance Figures Q1/26: Revenues EUR 796 m, 16.5 % adj. EBITDA margin, in/at the upper half/end of guidance range +9 % year-on-year like-for-like growth in the semiconductor core portfolio at constant FX Free cash flow of EUR 37 m (including disposal proceeds) ‘Simplify’ efficiency & transformation program delivered first savings Digital Photonics Strategy Progress: Augmented Reality smart glasses: full portfolio...
-

Investigational PET Tracer Iodine 124 Evuzamitide from Bayer Met Primary Endpoints in Phase III Study in Patients Suspected to Have Cardiac Amyloidosis

BERLIN & WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced positive topline results from the Phase III REVEAL study, an investigator-initiated study by Brigham and Women’s Hospital that evaluated the investigational PET/CT radiotracer I 124 evuzamitide.1,5 The study met the primary endpoints of sensitivity (the ability of a test to identify individuals who have the condition) and specificity (the ability of a test to identify individuals who do not have the condition) for the diagnosis of...
-

ABIONYX Pharma : Information relative au nombre total de droits de vote et d’actions composant le capital social

TOULOUSE, France--(BUSINESS WIRE)--Regulatory News: ABIONYX Pharma (Paris:ABNX): Place de cotation : Euronext Paris, Compartiment C Code ISIN : FR0012616852 Date Nombre de titres composant le capital en circulation Nombre total de droits de vote Total brut (1) Total net (2) 30 avril 2026 35 511 655 45 235 726 44 998 754  (1) Le nombre de droits de vote bruts (ou droits de vote “théoriques”) sert de base de calcul pour les franchissements de seuil. Conformément à l’article 223-11 du Règlement Gé...
-

ABIONYX Pharma: Monthly Statement of Total Voting Rights and Shares Forming the Company’s Share Capital

TOULOUSE, France--(BUSINESS WIRE)--Regulatory News: ABIONYX Pharma (Paris:ABNX): Market: Euronext Paris, Compartment C ISIN code: FR0012616852 Date Number of shares outstanding Total voting rights Total gross (1) Total net (2) April 30, 2026 35,511,655 45,235,726 44,998,754 (1) The total number of gross (or “theoretical”) voting rights is used as the basis for calculating threshold crossings. In accordance with Article 223-11 of the AMF General Regulations, this number is calculated on the basi...
-

Saba Capital Secures Major Liquidity Win for Herald Investment Trust Shareholders, Marking Sixth Successful Outcome of Seven Original UK Campaigns

LONDON--(BUSINESS WIRE)--Saba Capital Management, L.P. (together with certain of its affiliates, “Saba” or “we”), the largest shareholder of Herald Investment Trust PLC (HRI:LSE) (“HRI” or the “Company”), today announced that its engagement has delivered a landmark outcome for HRI shareholders. Following Saba’s negotiations with the Board, the Company has announced a tender offer for up to 66 percent of its issued share capital. Under the terms of the agreement, the tender offer will be availab...